On April 8, 2026 Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) ("Innate" or the "Company"), reported that Yannis Morel, Chief Operating Officer, will present at the AACR (Free AACR Whitepaper) Oncology Industry Partnering Event: From Cancer Discoveries to Patients. Yannis Morel will present in the Showcase Session 2 on Thursday, April 16, 2026, at 6:10 PM PDT, at the San Diego Convention Center in San Diego, California.
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
The AACR (Free AACR Whitepaper) Oncology Industry Partnering Event is an annual forum that brings together venture capitalists, investment bankers, biotech and pharmaceutical scientific and business leaders focused on oncology drug development and entrepreneurship. The showcase sessions provide selected biotechnology companies the opportunity to highlight their oncology pipelines, platforms, and strategies for innovation directly to an audience of analysts and investors.
"We are delighted to have been selected to present at the AACR (Free AACR Whitepaper) Oncology Industry Partnering Event, which is a unique forum bringing together biotech, pharma and investors. Innate Pharma’s selection to present during this forum is a recognition of our exciting clinical pipeline and provides a valuable opportunity to share the progress of our key assets including IPH4502 our Nectin-4 ADC. We look forward to the conversations that these interactions can spark and their potential to accelerate the development of our differentiated therapies for patients," said Yannis Morel, Chief Operating Officer of Innate Pharma.
Presentation Details
•AACR Oncology Industry Partnering Event: From Cancer Discoveries to Patients
•Session: Showcase Session 2, Meeting Room 11
•Date/Time: Thursday, April 16, 2026, 6:10 PM PDT
•Presenter: Yannis Morel, Chief Operating Officer, Innate Pharma
•Location: San Diego Convention Center, San Diego, California
(Press release, Innate Pharma, APR 8, 2026, View Source [SID1234664237])